Financials
Financial year 2025
SMECE Acute Medicine from Erpe-Mere, company number BE0737434481, closed financial year 2025 with a result of € 27,491 after tax. For that financial year SMECE Acute Medicine recorded a gross margin of € 35,299 and equity of € 35,572. Compared with financial year 2024, the result moved from € 38,231 to € 27,491. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 35,572
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 27,491
▼ 28% vs 2024
Profit after tax over the fiscal year.
€ 32,533
▲ 52% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 27,491 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 323
Supplier invoices still open on the last day of the fiscal year.
€ 10,629
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 21,006 | € 46,256 | € 52,555 | € 35,299 | ▼ 33% |
| Profit after taxes | € 10,285 | € 31,074 | € 38,231 | € 27,491 | ▼ 28% |
| Equity | € 35,572 | € 35,572 | € 35,572 | € 35,572 | |
| Total debts | € 5,434 | € 44,954 | € 39,767 | € 40,762 | ▲ 3% |
| Cash | € 18,182 | € 41,724 | € 21,386 | € 32,533 | ▲ 52% |
| Retained profit | € 34,572 | € 34,572 | € 34,572 | € 34,572 | |
| Dividend | € 0 | € 31,074 | € 38,231 | € 27,491 | ▼ 28% |
| Balance sheet total | € 41,006 | € 80,526 | € 75,339 | € 76,334 | ▲ 1% |
Key figures of SMECE Acute Medicine, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SMECE Acute Medicine?
What happened at SMECE Acute Medicine in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 27,491 (▼ 28% vs 2024). Source: NBB ↗
- New establishment in Erpe-Mere. KBO
- Cedric Smets became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 10,285 profit in 2022 to € 27,491 profit in 2025.
Paid € 41,420 in corporate taxes since 2022.
Best year ever: 2024, with € 38,231 profit.
Paid out € 96,796 in dividends to the owners in total.
A new publication or filing at SMECE Acute Medicine? We notify you, reason included.
Follow SMECE Acute MedicineDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SMECE Acute Medicine is Cedric Smets.
Directors
According to the 2025 annual accounts
Cedric Smets
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Populierenstraat 39
9420 Erpe-Mere
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0737.434.481
- VAT number
- BE 0737.434.481
- Registered office
- Populierenstraat 39, 9420 Erpe-Mere
- Names & denominations
- SMECE Acute Medicine
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 November 2019
- Peppol
- Active · Active since 15 Apr 2026
- Contact
- [email protected]